HILARY YOUNG: Open Payments
NPI 1013379601 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 36 payments from 8 companies in 2025. Trend: 2023 $1,441 · 2024 $1,350 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $377 |
| Biogen, Inc. | 8 | $258 |
| GENZYME CORPORATION | 5 | $192 |
| TG Therapeutics, Inc. | 5 | $122 |
| Genentech, Inc. | 1 | $80 |
| Genentech USA, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Celgene Corporation | 1 | $27 |
Products named: KESIMPTA, TYSABRI, BRIUMVI, Ocrevus, Ocrevus Zunovo, PONVORY, ZEPOSIA, VUMERITY.
Industry payments across OH — which companies pay providers there.
